Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1616 | 2015 |
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 437 | 2011 |
CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 404 | 2013 |
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ... Biomarkers in medicine 6 (4), 419-430, 2012 | 349 | 2012 |
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease NA Verwey, WM Van Der Flier, K Blennow, C Clark, S Sokolow, ... Annals of clinical biochemistry 46 (3), 235-240, 2009 | 209 | 2009 |
A normative study of the trail making test A and B in Greek adults I Zalonis, E Kararizou, NI Triantafyllou, E Kapaki, S Papageorgiou, ... The Clinical Neuropsychologist 22 (5), 842-850, 2008 | 186 | 2008 |
Highly increased CSF tau protein and decreased β-amyloid (1–42) in sporadic CJD: a discrimination from Alzheimer's disease? E Kapaki, K Kilidireas, GP Paraskevas, M Michalopoulou, E Patsouris Journal of Neurology, Neurosurgery & Psychiatry 71 (3), 401-403, 2001 | 184 | 2001 |
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 175 | 2018 |
Cerebrospinal fluid tau, phospho‐tau181 and β‐amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease EN Kapaki, GP Paraskevas, NG Tzerakis, C Sfagos, A Seretis, ... European journal of neurology 14 (2), 168-173, 2007 | 162 | 2007 |
Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ... Acta Neurologica Scandinavica 116 (6), 374-379, 2007 | 147 | 2007 |
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 143 | 2022 |
Update on vascular cognitive impairment associated with subcortical small-vessel disease A Wallin, GC Román, M Esiri, P Kettunen, J Svensson, GP Paraskevas, ... Journal of Alzheimer's Disease 62 (3), 1417-1441, 2018 | 134 | 2018 |
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ... Biomarkers in medicine 10 (1), 19-34, 2016 | 121 | 2016 |
Circulating interleukin‐10 and interleukin‐12 in Parkinson’s disease M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ... Acta Neurologica Scandinavica 119 (5), 332-337, 2009 | 118 | 2009 |
Neurofilament ELISA validation A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ... Journal of immunological methods 352 (1-2), 23-31, 2010 | 115 | 2010 |
CSF tau protein and β‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population E Kapaki, GP Paraskevas, I Zalonis, C Zournas European Journal of Neurology 10 (2), 119-128, 2003 | 111 | 2003 |
Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders E Kapaki, J Segditsa, C Papageorgiou Acta Neurologica Scandinavica 79 (5), 373-378, 1989 | 106 | 1989 |
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease-A consensus report A Wallin, E Kapaki, M Boban, S Engelborghs, DM Hermann, B Huisa, ... BMC neurology 17, 1-12, 2017 | 105 | 2017 |
Novel mutations and repeated findings of mutations in familial Alzheimer disease U Finckh, C Kuschel, M Anagnostouli, E Patsouris, GV Pantes, S Gatzonis, ... Neurogenetics 6, 85-89, 2005 | 105 | 2005 |
Increased cerebrospinal fluid tau protein in multiple sclerosis E Kapaki, GP Paraskevas, M Michalopoulou, K Kilidireas European neurology 43 (4), 228-232, 2000 | 105 | 2000 |